BETA

7 Amendments of Françoise GROSSETÊTE related to 2011/0429(COD)

Amendment 43 #
Proposal for a directive
Recital 6
(6) Numerous Union acts have been adopted since the adoption of Directive 2000/60/EC, which constitute emission control measures in accordance with Article 16 of that Directive for individual priority substances. Moreover, many environmental protection measures fall under the scope of other existing Union legislation. Therefore, priority should be given to implementing and revising existing instruments rather than establishing new controls. It would be appropriate to take a consistent policy approach regarding pharmaceutical substances, taking into consideration the full societal and medical implications, in full consultation with all relevant stakeholders. To this end, the Commission will produce a report with possible legislative proposals on the environmental effects of pharmaceutical substances for human use in waters and soils, under Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use1 and Regulation (EU) No. 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products2. The inclusion of a substance in Annex X to Directive 2000/60/EC is without prejudice to the application of the provisions of Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. _______________ 1 OJ L 348, 31.12.2010, p. 74 2 OJ L 348, 31.12.2010, p. 1
2012/11/13
Committee: ENVI
Amendment 171 #
Proposal for a directive
Annex I – table – row 46
Directive 2000/60/EC
Annex X – table – row 46
(46) 57-63-6 200-342-2 17alpha-ethinylestradiol deleted
2012/11/13
Committee: ENVI
Amendment 178 #
Proposal for a directive
Annex I – table – row 47
Directive 2000/60/EC
Annex X – table – row 47
(47) 50-28-2 200-023-8 17beta-estradiol deleted
2012/11/13
Committee: ENVI
Amendment 185 #
Proposal for a directive
Annex I – table – row 48
Directive 2000/60/EC
Annex X – table – row 48
(48) 15307-79-6 239-346-4 Diclofenac deleted
2012/11/13
Committee: ENVI
Amendment 205 #
Proposal for a directive
Annex II – table – row 46
Directive 2008/105/EC
Annex I – table – row 46
(46) 17alpha- 57-63-6 3,5 10-5 7 10-6 not not ethinylestradiol applicable applicable deleted
2012/11/13
Committee: ENVI
Amendment 210 #
Proposal for a directive
Annex II – table – row 47
(47) 17beta- 50-28-2 4 10-4 8 10-5 not not estradiol applicable applicable deleted
2012/11/13
Committee: ENVI
Amendment 215 #
Proposal for a directive
Annex II – table – row 48
Directive 2008/105/EC
Annex I – table – row 48
(48) Diclofenac 15307-79-6 0,1 0,01 not not applicable applicable deleted
2012/11/13
Committee: ENVI